Effector T cells and Cell-mediated Cytotoxicity Flashcards
Cell-Mediated Immunity
- recognize and eliminate cells that have been infected by virus/transformed into cancerous cells
- consists of antigen specific effector cells (CD4, CD8, natural killer T cells) an non specific effector cells (NK cells, macrophages, neutrophils, eosinophils)
- cell mediated immunity requires cytokines made by T cells, NK cells, NKT cells, dendritic cells and macrophages
Effector T cells do not require ? for activation
- do not require CD28 costimulation for activation following TCR triggering (unlike naive T cells)
- costimulatory signal may be provided by LFA-1 binding to ICAMs on target cells
Effector T cells Express Higher Levels of ? adhesion molecules than naive T cells
- CD2 and LFA-1
- allows efficient binding of effector T cells to target cells
Effector T cells express ?, low levels of ? and no ?
- CD44, which is upregulated following TCR signalling
- low levels of CD62L
- no CCR7 to prevent recirculation to secondary lymphoid tissue
Effector T cells traffic to…
- tertiary lymphoid tissues and sites of inflammation
- naive t cells traffic to high endothelial venules in secondary lymphoid tissues
Effector T cell lifespan
-live for days to weeks
Effector CD4+ T Cells-under the influence of…
- polarizing cytokines
- naive T cells that encounter cognate antigen differentiate into Th1, Th2, Th17, Tfh and Treg cells
FoxP3
Master Tc Regulator of induced Treg cell
T-Bet
Master Tc Regulator of th1 cell
- effector cytokines are IFN-gamma, TNF
- effector fxns are cell-mediated immunity, macrophage activation, inflammation
Effector CD4+ T cells express…
- membrane bound effector molecules (lymphotoxin, Cd40 ligand)
- soluble effector molecules (IFN gamma, TNF, ILs)
Functions of IFN-gamma and lymphotoxin
-promote macrophage activation by Th1 cells
Functions of CD40 ligand and IL-4
- promote B cell activation by Tfh and Th2 cells
- promote allergic inflammation by Th2 cells
Functions of IL-17 and IL-22 (Th17)
- secreted by Th17 cells
- promote inflammation
Functions of IL-10 and TGF-beta (Treg)
-downregulate cell. immune responses and inflammation
Effector Cd8+ T cells
- effector molecules are membrane bound Fas ligand, secreted IFN-gamma, TNF and cytotoxins (perforin and granzymes)
- perforin, granzymes and Fas ligand mediate target cell destruction by CTL
- secreted IFN-gamma and TNF enhance cell mediated immunity
CTL Effector molecules produced (4)
- cytotoxins (perforin and granzyme)
- IFN-gamma
- TNF
- FasL
CTL Mechanism of Killing
- cytotoxic granule release
- FasL-Fas interactions
NK T cell Effector molecules produced (5)
- IFN-gamma
- IL-4
- GMCSF
- IL-2
- TNF
NK T cell Mechanism of Killing
- FASL interactions predominantly
- can activate NK cells indirectly
NK cell Effector molecules produced (4)
- cytotoxins (performs and granzymes)
- IFN-gamma
- TNF
- FASL
NK cell Mechanism of Killing
- cytotoxic granule release
- FasL-Fas interactions
Generation of Antigen-specific CTL-class I MHC
-class I MHC restricted CD8+ T cells eliminate any altered cells (virus/cancer) in the body since all nucleated cells express MHC class I molecules
Generation of Antigen-specific CTL-activation phase
-stimulation of naive precursor CTL (CTL-P)
Generation of Antigen-specific CTL-Effector Phase
-differentiated CTL engage and kill targets
Generation of Antigen-specific CTL-licensing
- antigen presenting dendritic cells licensed by th1 or h17 cells via class II MHC-TCR and CD40-CD40L interactions
- or by activation of TLRs on the dendritic cells by microbial products
Generation of Antigen-specific CTL-Activation of Naive CTL-Ps
- activated via TCR triggering by foreign antigen/class I MHC complexes
- costimulation provided by CD28-CD80/CD86 interactions
- IL-2 provided by CD4 t cells, CD8 T cells interacting with the high affinity IL-2 receptor
- CTL-Ps express high affinity IL-2 receptors that enable them to respond to IL-2
- also secrete IL2 but not in sufficient amounts for CTL autocrine growth and differentiation
Memory CTL-Ps
- may secrete sufficient IL-2 for proliferation and differentiation into effector CTL
- CD4+ T cell helps development of memory CD8+ T cells
Role of IL-2 in CTL Response
- CTL and Th1 need IL2 for proliferation and differentiation
- for expression of genes coding for cytotoxic effector molecules (perforin, granzymes) stored in cytoplasmic granules
- in the absence of IL2, th1 and CTLs undergo apoptosis–> rapid termination of immune response once the pathogen has been eliminated
Effector Phase of CTL Response- Tc1 or Tc2 cells
Activated CD8 T cells may develop into:
- Tc1 that secrete IFN-gamma and kill by perforin and FasL
- or Tc2 cells that secrete IL4 but only small amnts of IFN-gamma and kill by perforin
Effector Phase of CTL Response-Conjuate Formation
- involves TCR recognition of foreign peptide presented by class I MHC on the target cell
- CD8 and LFA-1 stabilize this interaction
- TCR signalling causes transient increase in avidity of LFA-1 for ICAMs on the target cell that persists for 5-10 mins
Effector Phase of CTL Response-Release of Cytotoxins
- golgi stacks and storage granules containing cytotoxins reorient in the cytoplasm and conc. near the interface b/w the CTL and target cell
- CTL release storage granule contents into the space b/w the 2 cells
Effector Phase of CTL Response-Perforin
-perforin monomers, in the presence of Ca change confirmation to allow them to insert into target cell membrane, polymerize into pores, trigger endocytosis in response to membrane damage
Effector Phase of CTL Response-Granzyme B
- Granzyme B binds to mannose-6P receptors on target cells, complexes are internalized within vesicles
- perforin then allows granzyme B to be released from the vesicle into cytoplasm
- cleaves substrates to initiate apoptosis
Effector Phase of CTL Response-Fas/FasL Pathway
- the interaction of FasL on CTL w/ Fas on target cells leads to apoptosis
- independent of Ca
Effector Phase of CTL Response-Caspases
- cysteine proteases that cleave proteins after an aspartic acid residue
- perforin/granzyme and Fas/FasL pathway result in activation of caspase-3
- leads to activation of endonucleases that fragment nucleosomal DNA and additional proteases that disassemble the cytoskeleton of the cell
Effector Phase of CTL Response-viral DNA
- also fragmented during CTL killing of target cells
- prevents viral rep. during the interval before target cell destruction
Effector Phase of CTL Response-Serpins
-CTL protect themselves from the cytotoxic effects on their own perforin and granzyme by expressing serine protease inhibitors (serpins) that inhibit granzyme B
NK cells
- non specific cytotoxic effector cells
- important in defending against viruses and cancer
NK cell development
- arise from the same progenitor cells as T cells but do not develop exclusively in the thymus
- express IL2R beta chains, CD2, CD16
- do not express TCR, CD3, CD8
NK cell target cell recognition
- not MHC restricted
- some NK cells appear to have immunological memory
NK cells as a source of IFN-gamma (3)
- increases the microbicidal activity of macrophages
- promotes Th1 differentiation
- inhibits th2 development
- drives CTL generation
NK cells as a first line of defence
-first line of defence against viral infection b/c rapidly activated by IFN alpha and beta (made by virus infected cells to inhibit vrep. and protect neighbouring cells), IL12 produced by dendritic cells
NK Cell Effector Function-Constitutively active
-since they have cytoplasmic granules w/ perforin and granzyme and express FasL before encountering target cells
NK Cell Effector Function-Opposing-signals model
- to distinguish altered self cells from normal
- one category delivers an activating signal, while the other delivers an inhibitory signal
- the balance b/w opposing signals determines whether an NK cell will kill the target cell
- inhibitory signals override activation signals–> prevents NK cell mediated cytotoxicity, cytokine synthesis and proliferation
NK Cell Effector Function-Activating Receptor C-type lectins
-recognize altered carb structures on virus infected/cancer cells
NK Cell Effector Function-Inhibitory Receptors
- lectin like inhibitory receptors
- killer cell inhibitory receptors
- deliver an inhibitory signal following interaction w/ class I MHC
- target cells w/ low levels of MHC class I are killed while target cells w/ normal expression are spared
Antibody-dependent Cell mediated cytotoxicity (ADCC)
- NK cells, neutrophils, eosinophils, monocytes and macrophages express receptors for the Fc region of IgG (e.g. CD16 on NK cells)
- allows ADCC reactions-> non-specific killer cells are directed to IgG coated target cells
Antibody-dependent Cell mediated cytotoxicity (ADCC)-Neutrophils, Eosinophils, macrophages
- those activated through their Fc receptors become more metabolically active and release the lytic contents of their cytoplasmic lysosomes
- monocytes and macrophages secrete TNF, which is able to kill certain target cells
Antibody-dependent Cell mediated cytotoxicity (ADCC)-NK cells
- those that are activated through CD16 exocytose the contents of their cytoplasmic granules and kill by Fas/FasL pathway
- secretes TNF which is able to kill certain target cells
Signalling through CD16
- also an important activating receptor for NK cells
- causes phosphorylation of itams
- creates docking station for syk
- phosphorylation of adaptor cells
- activation of second messengers
- results in activation (prod. of cytokines, enhancement of phagocytic activity)
What are NKT cells?
- CD+/CD4- T cells that express NK cells and an invariant alpha/beta TCR that interacts w/ CD1d on APC and epithelial cells, which presents lipid and glycolipid antigens
- bridge innate and adaptive immunity
NKT cells as helper cells
- act as helper cells by secreting large amnts of cytokines that can support antibody formation (IL4) or inflammation and CTL expansion (IFN gamma) depending on the nature of the stimulus
- have FasL mediated cytotoxic effector fxn
NKT cell function
- rapid response system to provide early help against pathogens and malignant cells while T helper cell development is taking place
- guide development of the appropriate immune response (humeral or cellular)